4 completed, 1 unknown, 1 withdrawn. 3 Phase 4, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Ivermectin: new trials by email Literature Review of Ivermectin trials Research Report on Ivermectin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison Effectiveness of Oral Ivermectin , 1% Permethrin Shampoo and 4% Dimeticone Liquid Gel in the Treatment of Pediculosis Capitis Among School Children in Chachoengsao Province, Thailand Oral Ivermectin, 4% dimenticone liquid gel - Pediculus Capitis Infestation, Permethrin Adverse Reaction | Phase 4 | Unknown | Phramongkutklao College of Medicine and Hospital | 117 | 2023-12-15 | 2024-03-27 |
| The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19 Ivermectin, Prophylaxis - SARS-CoV-2, Ivermectin | Phase 4 | Withdrawn | Centre for Infectious Disease Research in Zambia | 2021-10-01 | 2022-02-03 | |
| A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh Ivermectin + Doxycycline, Hydroxychloroquine + Azithromycin - Ivermectin, Hydroxychloroquine | Completed | Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar | 116 | 2020-05-02 | 2020-06-16 | |
| Ivermectin and Human Immunity Ivermectin, Placebo - Ivermectin | Early Phase 1 | Completed | University of Georgia | 12 | 2018-02-12 | 2019-07-12 |
| Efficacy Study Between Two Different Dosages of an Antiparasitic in Patients With Crusted Scabies Ivermectin 200 µg/kg, Ivermectin 400 µg/kg - Gale, Severe Forms of Scabies | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 133 | 2017-10-11 | 2023-09-22 |
| Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy Ivermectin - Ivermectin, Onchocerciasis | Phase 4 | Completed | Robert Colebunders | 91 | 2017-10-01 | 2019-01-07 |
COVID-19 (1) · Epilepsy (1) · Galactosemias (1) · Lice Infestations (1) · Onchocerciasis (1)
Infections (3) · Brain Diseases (2) · Central Nervous System Diseases (2) · Nervous System Diseases (2) · Parasitic Diseases (2) · Skin Diseases (2) · Skin Diseases, Infectious (2) · Skin Diseases, Parasitic (2) · Skin and Connective Tissue Diseases (2) · Brain Diseases, Metabolic (1) · Brain Diseases, Metabolic, Inborn (1) · Carbohydrate Metabolism, Inborn Errors (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Coronaviridae Infections (1) · Coronavirus Infections (1)
Ivermectin (6) · Azithromycin (1) · Doxycycline (1) · Hydroxychloroquine (1)
Assistance Publique - Hôpitaux de Paris (1) · Centre for Infectious Disease Research in Zambia (1) · Phramongkutklao College of Medicine and Hospital (1) · Robert Colebunders (1) · University of Georgia (1) · Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar (1)
Bangladesh (1) · Democratic Republic of the Congo (1) · France (1) · Thailand (1) · United States (1) · Zambia (1)
Adrian J Wolstenholme, PhD (1) · Michel Mandro, MD (1) · Mohammad Shahbaz, MBBS, MCPS (1)
PMID 28855148, PMID 31314757, PMID 31923177, PMID 34090504, PMID 42090793, PMID 42480517